Boutique pharma focus Cambridge Solutions operates as a boutique pharmaceutical consulting firm offering disease area reports, news tracking, and conference coverage. This specialization creates opportunities to upsell deeper, tailored market intelligence packages to clients ranging from discovery-phase firms to Top 10 pharma companies and investors seeking competitive edge.

Small but strategic With a lean team of 2-10 employees, the firm can be targeted for high-margin, project-based engagements such as executive briefings, subscription services, and custom analyses, making it attractive to mid-market pharma clients that need expert insights without a large overhead.

Global access leverage The claim of global market access can be leveraged to cross-sell international DTP, regulatory, and competitive landscape analyses to multinational clients seeking consistent coverage across regions, potentially increasing deal size.

Tech-enabled delivery Usage of Microsoft 365, Google Cloud, Sentry, and Wix-based tools indicates modern, cloud-enabled service delivery. This supports scalable reporting, secure collaboration, and potential for a client portal or automated reporting subscriptions to improve retention.

Growth-ready funding range Revenue in the $1M-$10M band combined with a specialized pharma focus positions Cambridge Solutions to pursue growth through strategic partnerships, retainer-based advisory, and targeted bids on larger R&D intelligence and conference coverage contracts from larger biopharma players and investors.